HIV-seropositive results, health-related quality of life, and social support: A 24-week prospective study in Thailand

Although the health-related quality of life (HRQOL) and social support (SS) after the acknowledgement of human immunodeficiency virus (HIV)-seropositive results are important issues in HIV acquired immune deficiency syndrome (AIDS) counseling, they have not yet been fully studied. The investigators...

Full description

Saved in:
Bibliographic Details
Main Authors: Srisurapanont M., Sombatmai S., Jarusuraisin N.
Format: Article
Language:English
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-0035042267&partnerID=40&md5=a1496eab2ef8a8b843e458a27b9ebf0a
http://www.ncbi.nlm.nih.gov/pubmed/11359663
http://cmuir.cmu.ac.th/handle/6653943832/1885
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English
id th-cmuir.6653943832-1885
record_format dspace
spelling th-cmuir.6653943832-18852014-08-30T02:00:13Z HIV-seropositive results, health-related quality of life, and social support: A 24-week prospective study in Thailand Srisurapanont M. Sombatmai S. Jarusuraisin N. Although the health-related quality of life (HRQOL) and social support (SS) after the acknowledgement of human immunodeficiency virus (HIV)-seropositive results are important issues in HIV acquired immune deficiency syndrome (AIDS) counseling, they have not yet been fully studied. The investigators examined the healthy HIV patients's HRQOL and SS in a 24-week prospective study design. The HRQOL and SS of a participant were assessed by using Quality of Life Index (QL-Index) and Social Relationship Scale (SRS), respectively. The QL-Index, SRS quality (SRS-Q), and SRS extent of network (SRS-EN) scores were rated at baseline (week 0), week 12, and week 24. The significant differences of QL-Index, SRS-Q, and SRS-EN scores obtained at three points of time were initially analyzed by using a repeated measure multivariate analysis of variance (MANOVA). For those significantly different scores, a paired t test was applied to determine the significant difference of a pair of scores. Sixty-nine healthy individuals who had never had HIV tests participated in this study. Of these, 37 were HIV-seropositive. The HRQOL and SS of 37, 30, and 27 HIV-seropositive participants were evaluated at week 0, at week 12, and week 24, respectively. No significant difference was found among QL-Index scores and among SRS-Q scores obtained at those three points of time. However, SRS-EN scores obtained at week 24 were significantly higher than those obtained at week 0 and at week 12. In conclusion, an HIV-seropositive result by itself does not have much impact on a healthy HIV patient's HRQOL and SS. In contrast, his or her SS seems to be widened over time. 2014-08-30T02:00:13Z 2014-08-30T02:00:13Z 2001 Article 10872914 10.1089/10872910151133765 11359663 APCSF http://www.scopus.com/inward/record.url?eid=2-s2.0-0035042267&partnerID=40&md5=a1496eab2ef8a8b843e458a27b9ebf0a http://www.ncbi.nlm.nih.gov/pubmed/11359663 http://cmuir.cmu.ac.th/handle/6653943832/1885 English
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
language English
description Although the health-related quality of life (HRQOL) and social support (SS) after the acknowledgement of human immunodeficiency virus (HIV)-seropositive results are important issues in HIV acquired immune deficiency syndrome (AIDS) counseling, they have not yet been fully studied. The investigators examined the healthy HIV patients's HRQOL and SS in a 24-week prospective study design. The HRQOL and SS of a participant were assessed by using Quality of Life Index (QL-Index) and Social Relationship Scale (SRS), respectively. The QL-Index, SRS quality (SRS-Q), and SRS extent of network (SRS-EN) scores were rated at baseline (week 0), week 12, and week 24. The significant differences of QL-Index, SRS-Q, and SRS-EN scores obtained at three points of time were initially analyzed by using a repeated measure multivariate analysis of variance (MANOVA). For those significantly different scores, a paired t test was applied to determine the significant difference of a pair of scores. Sixty-nine healthy individuals who had never had HIV tests participated in this study. Of these, 37 were HIV-seropositive. The HRQOL and SS of 37, 30, and 27 HIV-seropositive participants were evaluated at week 0, at week 12, and week 24, respectively. No significant difference was found among QL-Index scores and among SRS-Q scores obtained at those three points of time. However, SRS-EN scores obtained at week 24 were significantly higher than those obtained at week 0 and at week 12. In conclusion, an HIV-seropositive result by itself does not have much impact on a healthy HIV patient's HRQOL and SS. In contrast, his or her SS seems to be widened over time.
format Article
author Srisurapanont M.
Sombatmai S.
Jarusuraisin N.
spellingShingle Srisurapanont M.
Sombatmai S.
Jarusuraisin N.
HIV-seropositive results, health-related quality of life, and social support: A 24-week prospective study in Thailand
author_facet Srisurapanont M.
Sombatmai S.
Jarusuraisin N.
author_sort Srisurapanont M.
title HIV-seropositive results, health-related quality of life, and social support: A 24-week prospective study in Thailand
title_short HIV-seropositive results, health-related quality of life, and social support: A 24-week prospective study in Thailand
title_full HIV-seropositive results, health-related quality of life, and social support: A 24-week prospective study in Thailand
title_fullStr HIV-seropositive results, health-related quality of life, and social support: A 24-week prospective study in Thailand
title_full_unstemmed HIV-seropositive results, health-related quality of life, and social support: A 24-week prospective study in Thailand
title_sort hiv-seropositive results, health-related quality of life, and social support: a 24-week prospective study in thailand
publishDate 2014
url http://www.scopus.com/inward/record.url?eid=2-s2.0-0035042267&partnerID=40&md5=a1496eab2ef8a8b843e458a27b9ebf0a
http://www.ncbi.nlm.nih.gov/pubmed/11359663
http://cmuir.cmu.ac.th/handle/6653943832/1885
_version_ 1681419754040983552